Thai FDA Drug Registration Timeline: Step-by-Step Guide for Foreign Manufacturers

Overview of Thailand FDA Drug Registration

Thailand's Food and Drug Administration (Thai FDA), operating under the Ministry of Public Health, is the regulatory authority responsible for approving all pharmaceutical products sold or imported into Thailand. For foreign manufacturers — including Taiwan generic pharmaceutical exporters — understanding the registration timeline is essential for market entry planning.

Who Registers the Product?

In Thailand, the product registration applicant must be a locally licensed pharmaceutical importer. The Taiwan manufacturer is named as the manufacturing site on the registration dossier, but the legal applicant and license holder is always the Thailand-based importing entity.

Pre-Submission Requirements

Before submitting to Thai FDA, the importer and manufacturer must ensure the following are in place:

• →Manufacturer GMP Certificate issued by TFDA or another PIC/S-member authority — currently valid
• →Certificate of Pharmaceutical Product (CPP) issued by TFDA, covering the specific product
• →Complete ACTD Dossier — all four parts: Administrative, Quality, Nonclinical, and Clinical
• →Zone IVb Stability Data — long-term stability at 40°C / 75% relative humidity per ICH Q1A
• →Bioequivalence (BE) Study Report — required for most oral solid dosage forms
• →Thai-language labeling artwork — compliant with Thai FDA label requirements

Standard Registration Pathway and Timeline

Step 1: Dossier Preparation (3–6 months) This phase is handled by the Taiwan manufacturer in collaboration with the Thailand importer's regulatory affairs team. Missing documents at this stage are the most common cause of downstream delays.

Step 2: Pre-screening Review (1–2 months) Thai FDA conducts an initial administrative review to confirm completeness. Incomplete submissions are returned with a deficiency list.

Step 3: Technical Review — Quality Module 3 (6–12 months) This is the longest phase. Thai FDA's drug quality reviewers assess the full quality dossier. Each query round adds 2–4 months.

Step 4: Technical Review — Nonclinical and Clinical (2–6 months) For most generic drugs with bioequivalence data, this review is streamlined.

Step 5: GMP Inspection if required (1–3 months additional) Thai FDA may request a GMP inspection for new manufacturers. PIC/S GMP-certified Taiwan manufacturers typically satisfy inspection requirements more efficiently.

Step 6: Registration Approval and License Issuance Thai FDA issues a drug registration certificate valid for 5 years and must be renewed before expiry.

Realistic Total Timeline

Common Causes of Delay

• →Incomplete or poorly organized ACTD dossier at submission
• →Missing or expired GMP certificate at time of review
• →Stability data not conducted under Zone IVb conditions
• →BE study conducted at non-GCP-accredited facility
• →Thai-language labeling deficiencies
• →Slow query response from manufacturer (>3 months per round)

Summary

Thailand FDA drug registration for imported generic pharmaceuticals typically takes 18–30 months under normal conditions. Manufacturers who prepare complete ACTD dossiers — particularly with Zone IVb stability data and valid PIC/S GMP certification — are best positioned for efficient registration outcomes.